Updated January 2014

Despite considerable efforts, there is no phase III evidence at this time that any type of targeted therapy or immunotherapy has any role in the treatment of small cell lung cancer.

Reference:

1 Abidin AZ, Garassino MC, Blackhall F, et al. Targeted therapies in small cell lung cancer: a review. Ther Adv Med Oncol 1:25-37, 2010

2 Murray N, Salgia R, Fossella F. Targeted molecules in small cell lung cancer. Semin Oncol 31:106-111, 2004